Non invasive Intracranial Pressure Monitoring Device Sales

The global Non-Invasive Intracranial Pressure (ICP) Monitoring Device market is projected to reach a value of approximately USD 1.8 billion by 2035, growing at a compound annual growth rate (CAGR) of around 9.2% from 2025 to 2035. This growth can be attributed to the increasing prevalence of neurological disorders, which necessitate continuous monitoring of intracranial pressure for effective patient management. Furthermore, advancements in medical technology and growing awareness among healthcare professionals about the benefits of non-invasive procedures are contributing factors to the market's expansion. The rising demand for early diagnosis and treatment of conditions such as traumatic brain injury, stroke, and brain tumors is further propelling the need for these devices. Additionally, the increasing investment in healthcare infrastructure, particularly in emerging economies, is expected to fuel the market's growth in the coming years.

Growth Factor of the Market

The growth of the Non-Invasive ICP Monitoring Device market can be significantly attributed to several key factors. First, the evolution of healthcare technology has led to the development of sophisticated non-invasive monitoring devices that provide accurate and reliable data on intracranial pressure. These technological advancements have fostered an environment conducive to enhanced patient care, especially in emergency and critical care settings. Secondly, as neurological disorders become increasingly prevalent worldwide, hospitals and healthcare facilities are adopting non-invasive monitoring as a standard practice in patient evaluation. This trend is further supported by clinical studies that highlight the need for effective monitoring solutions to mitigate the risks associated with high intracranial pressure. Furthermore, the growing geriatric population, which is more susceptible to neurological conditions, is also contributing to the rising demand for these devices. Lastly, favorable reimbursement policies related to non-invasive procedures are encouraging healthcare providers to invest in such technologies, thereby driving market growth.

Key Highlights of the Market

• The non-invasive ICP monitoring market is expected to grow at a CAGR of 9.2% from 2025 to 2035.
• The increasing prevalence of neurological disorders globally is a significant growth driver.
• Technological advancements in medical devices are enhancing patient care and monitoring accuracy.
• Favorable reimbursement policies are encouraging adoption among healthcare providers.
• The growing geriatric population is fueling demand for non-invasive monitoring solutions.

By Product Type

Non-Invasive ICP Sensors:

Non-Invasive ICP Sensors are crucial components of the intracranial pressure monitoring ecosystem. These sensors utilize advanced technologies to detect intracranial pressure without the need for invasive procedures. They offer several advantages, including reduced risk of infection, shorter recovery times, and improved patient comfort. The ability to provide real-time data is essential for clinicians in critical care settings, enabling timely interventions. As technology continues to evolve, these sensors are becoming more sophisticated, offering enhanced accuracy and reliability, thus driving demand in the market. The increasing adoption of these sensors in hospitals and surgical centers is contributing positively to the overall market growth.

Non-Invasive ICP Monitors:

Non-Invasive ICP Monitors play a vital role in the effective management of patients with potential intracranial pressure concerns. These devices integrate advanced monitoring algorithms that provide continuous data of intracranial pressure levels, enabling healthcare professionals to make informed decisions regarding patient care. With the rising focus on enhancing patient safety and outcomes, more hospitals are investing in these monitors as part of their standard equipment. The non-invasive nature of these monitors not only reduces the risk of complications but also enhances the overall patient experience, contributing to their increased adoption in various healthcare settings.

Non-Invasive ICP Transducers:

Non-Invasive ICP Transducers are critical devices that facilitate the measurement of pressure changes within the cranial cavity. These transducers operate based on the principle of converting mechanical pressure into an electrical signal, which can be monitored and recorded. Their non-invasive nature allows for continuous monitoring without the need for surgical intervention, making them an attractive option for healthcare providers. Transducers are particularly beneficial in emergency departments and intensive care units, where rapid assessment of intracranial pressure is vital. As awareness of the importance of such measurements grows, the demand for non-invasive ICP transducers is anticipated to rise significantly.

Non-Invasive ICP Systems:

Non-Invasive ICP Systems encompass a complete setup designed for the continuous monitoring of intracranial pressure without the need for invasive procedures. These systems integrate various components such as sensors, monitors, and data analysis software to provide comprehensive insights into patient conditions. Their ability to deliver timely information regarding pressure fluctuations has made them indispensable in modern healthcare environments. Healthcare facilities are increasingly recognizing the benefits of these systems, including improved patient outcomes and efficiency in monitoring processes. This growing recognition is expected to drive the adoption of non-invasive ICP systems in hospitals and clinics worldwide.

Non-Invasive ICP Capsules:

Non-Invasive ICP Capsules represent the latest innovation in the field of intracranial pressure monitoring. These capsules are designed to be implanted non-invasively and provide accurate measurements of intracranial pressure over extended periods. They are particularly useful in outpatient settings, enabling continuous monitoring for patients who may not require hospitalization. The ability to collect data without invasive procedures enhances patient comfort and compliance, which is critical in chronic care scenarios. As the healthcare industry shifts toward more patient-centric approaches, the demand for non-invasive ICP capsules is expected to witness significant growth, paving the way for new advancements in this space.

By Application

Hospitals:

The hospital segment holds a significant share of the Non-Invasive ICP Monitoring Device market, primarily due to the high demand for advanced monitoring solutions in critical care settings. Hospitals are increasingly incorporating non-invasive devices into their protocols to ensure the safety and well-being of patients suffering from conditions such as traumatic brain injuries, strokes, and other neurological disorders. The ability to monitor intracranial pressure continuously and non-invasively allows healthcare providers to intervene proactively, which is crucial for patient outcomes. Furthermore, the rising number of patients requiring such monitoring further strengthens the market position of non-invasive ICP devices within hospital settings, driving their adoption in emergency departments and intensive care units.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are emerging as a key application area for Non-Invasive ICP Monitoring Devices. These centers focus on providing same-day surgical care and are increasingly utilizing non-invasive monitoring options to enhance patient safety and satisfaction. The non-invasive nature of these devices aligns perfectly with the ASC model, as they promote rapid recovery times and minimize complications associated with traditional invasive monitoring methods. ASCs benefit from the ability to monitor patients post-surgery effectively, allowing for early identification of potential complications related to intracranial pressure. As the number of ASCs continues to rise, their contribution to the non-invasive ICP monitoring market is expected to grow substantially.

Clinics:

Clinics also represent an important application segment for Non-Invasive ICP Monitoring Devices. These healthcare facilities are increasingly recognizing the value of non-invasive methods in diagnosing and managing patients with neurological issues. Non-invasive monitoring allows clinics to provide better care without the need for complex procedures, making it a preferred choice for both healthcare providers and patients. Furthermore, as clinics expand their services to include more neurological assessments and treatments, the demand for these devices is projected to increase. With a growing focus on patient-centered care, clinics are likely to adopt non-invasive ICP monitoring solutions to enhance their diagnostic capabilities and overall patient experience.

Others:

The 'Others' category encompasses various healthcare settings where Non-Invasive ICP Monitoring Devices can be utilized. This includes rehabilitation centers, research institutions, and specialty clinics that focus on neurological care. As awareness regarding the importance of monitoring intracranial pressure spreads, these settings are increasingly exploring the use of non-invasive devices to enhance patient outcomes. The versatility of non-invasive ICP monitoring technologies allows them to be adapted for various applications outside traditional hospital environments. This adaptability is expected to drive the growth of the 'Others' segment in the non-invasive ICP monitoring market as demand for innovative monitoring solutions expands across diverse healthcare scenarios.

By Distribution Channel

Direct Sales:

The direct sales channel is a significant segment in the distribution of Non-Invasive ICP Monitoring Devices. Manufacturers and suppliers often sell their products directly to hospitals, clinics, and healthcare providers, ensuring that end-users receive the necessary support and training for effective device usage. This approach allows for a stronger relationship between manufacturers and healthcare facilities, fostering collaboration in terms of product development and feedback. Direct sales are particularly advantageous in the medical device industry as they help streamline the supply chain, reduce costs, and enhance customer satisfaction by providing personalized services. The continuous growth in healthcare infrastructure worldwide is likely to bolster direct sales of non-invasive ICP monitoring devices, further driving market growth.

Distributor Sales:

Distributor sales serve as another critical channel for the distribution of Non-Invasive ICP Monitoring Devices, allowing manufacturers to reach a broader market. Distributors often have established relationships with healthcare facilities, enabling them to introduce non-invasive monitoring solutions effectively. This channel is essential for manufacturers looking to penetrate various regions and expand their market presence. Distributors can also provide value-added services, such as logistics, inventory management, and after-sales support, which can significantly benefit healthcare providers. As the demand for non-invasive monitoring devices rises, the distributor sales channel is expected to play a pivotal role in facilitating product availability across diverse healthcare settings.

By Technology

Microstrain Sensor Technology:

Microstrain Sensor Technology is a prominent innovation in the Non-Invasive ICP Monitoring Device market. This technology is designed to measure minute changes in intracranial pressure through highly sensitive sensors that utilize strain gauges. The non-invasive nature of microstrain sensors allows for continuous monitoring without the risks associated with invasive procedures. These sensors are particularly effective in providing real-time data, enabling healthcare professionals to make informed decisions regarding patient care. As hospitals and clinics increasingly adopt microstrain sensor technology, it is expected to significantly contribute to the overall growth of the non-invasive ICP monitoring market.

Optoacoustic Sensor Technology:

Optoacoustic Sensor Technology represents a cutting-edge approach to non-invasive intracranial pressure monitoring. This technology employs a combination of light and ultrasound to measure pressure changes within the cranial cavity, providing highly accurate readings without the need for invasive interventions. The ability to deliver real-time data makes optoacoustic sensors particularly valuable in critical care settings, where timely interventions can be lifesaving. As advancements in optoacoustic technology continue to emerge, its adoption in healthcare facilities is anticipated to grow, thereby enhancing the capabilities of non-invasive ICP monitoring solutions.

Transcranial Doppler Technology:

Transcranial Doppler Technology is another significant innovation within the Non-Invasive ICP Monitoring Device arena. This technique utilizes ultrasound waves to assess blood flow dynamics within the brain's vasculature, indirectly estimating intracranial pressure levels. By measuring the velocity of blood flow, healthcare professionals can infer changes in intracranial pressure, making it a useful tool for monitoring neurological patients. Its non-invasive nature makes it an attractive option for use in both inpatient and outpatient settings. As the understanding of cerebral hemodynamics improves, the adoption of transcranial Doppler technology is expected to increase, further driving market growth.

MRI Technology:

MRI Technology has emerged as a valuable non-invasive method for assessing intracranial pressure. This imaging technique provides high-resolution images of the brain and its structures, allowing for the evaluation of potential complications associated with elevated intracranial pressure. While primarily used for diagnostic purposes, MRI can also assist in monitoring pressure changes in patients with known neurological issues. The increasing availability of MRI machines within healthcare facilities, coupled with advancements in imaging technology, is expected to bolster the adoption of this method for non-invasive ICP monitoring. As healthcare providers seek to enhance diagnostic accuracy, MRI technology will likely play a crucial role in the non-invasive monitoring landscape.

Other:

The 'Other' category encompasses various emerging technologies that contribute to non-invasive ICP monitoring solutions. Innovations in biosensor technology, wearable devices, and telemedicine applications are all on the rise, offering new possibilities for measuring intracranial pressure without invasive methods. As research continues in these areas, the non-invasive ICP monitoring market is likely to see new entrants and novel technologies that enhance patient care. The integration of advanced algorithms and data analytics will also play a crucial role in improving the precision and reliability of these technologies, ultimately shaping the future of non-invasive ICP monitoring devices.

By Region

The Non-Invasive Intracranial Pressure Monitoring Device market exhibits diverse growth across various regions, with North America leading the charge. This region is projected to account for approximately 45% of the global market share by 2035, driven by the presence of advanced healthcare infrastructure, a growing population with neurological disorders, and continuous research and development in medical technologies. The United States, in particular, is the largest market contributor, showcasing high adoption rates of innovative medical devices and favorable reimbursement policies. The CAGR for North America is anticipated to be around 8.5%, reflecting the region's robust healthcare ecosystem and demand for non-invasive monitoring solutions.

Europe is another significant region in the Non-Invasive ICP Monitoring Device market, expected to capture about 30% of the global market share by 2035. The European market is characterized by the increasing prevalence of neurological conditions and a strong emphasis on patient safety and comfort, influencing the adoption of non-invasive devices. Countries such as Germany, France, and the UK are leading the way in technological advancements and healthcare innovations. The CAGR for the European market is projected to be approximately 7.8%, driven by regulatory support and the expansion of healthcare facilities. Both North America and Europe are expected to continue dominating the market, while regions such as Asia Pacific and Latin America are anticipated to experience significant growth due to improving healthcare infrastructure.

Opportunities

The Non-Invasive Intracranial Pressure Monitoring Device market is poised to experience considerable opportunities as healthcare technology continues to evolve. One of the major opportunities lies in the expanding geriatric population across the globe. As older adults are more susceptible to neurological disorders that necessitate ICP monitoring, healthcare providers are increasingly looking for non-invasive solutions to address this growing demand. This demographic shift presents a significant opportunity for manufacturers to innovate and develop advanced non-invasive monitoring devices tailored to the unique needs of elderly patients. Furthermore, the rise of telemedicine and remote patient monitoring is creating new avenues for integrating non-invasive ICP monitoring devices into everyday healthcare practices, thereby enhancing patient care while reducing hospital visits.

Another key opportunity in the market is the increasing investment in healthcare infrastructure, particularly in emerging economies. Countries in Asia Pacific, Latin America, and parts of the Middle East and Africa are witnessing rapid growth in their healthcare sectors, with governments and private investors allocating substantial funds to enhance medical services and technologies. This burgeoning healthcare landscape presents significant opportunities for non-invasive ICP monitoring device manufacturers to establish a foothold in these regions. By addressing the unique challenges posed by various healthcare systems and providing affordable yet effective monitoring solutions, companies can tap into this expanding market and benefit from the region's growing need for advanced medical technologies.

Threats

Despite the promising growth of the Non-Invasive Intracranial Pressure Monitoring Device market, there are several threats that could hinder its progress. One of the most significant challenges is the presence of stringent regulatory requirements for medical devices. Manufacturers must navigate complex approval processes, which can delay the introduction of innovative products into the market. Additionally, companies face pressure to comply with evolving regulations, which may vary considerably across different regions. This regulatory landscape can create barriers for new entrants and may lead to increased costs associated with compliance, ultimately impacting the growth of the market.

Another potential threat to this market is the competition from invasive ICP monitoring methods, which have been standard practice for many years. Many healthcare facilities may still prefer traditional invasive techniques due to their established efficacy and reliability. Convincing medical professionals to transition to non-invasive options may require significant educational efforts and clinical validation to showcase the benefits of non-invasive monitoring. Furthermore, if non-invasive devices fail to demonstrate comparable accuracy and reliability to their invasive counterparts, healthcare providers may be hesitant to adopt them, leading to potential resistance in the market.

Competitor Outlook

• Medtronic plc
• Codman & Shurtleff, Inc.
• Integra LifeSciences Corporation
• Raumedic AG
• Neurotech Solutions, Inc.
• NeuroVive Pharmaceutical AB
• ElMindA Ltd.
• Natus Medical Incorporated
• Vyaire Medical, Inc.
• Honeywell International Inc.
• Philips Healthcare
• Siemens Healthineers
• Guangzhou Med Equipment Co., Ltd.
• HeadSense Medical Ltd.
• Neuroscience Inc.

The competitive landscape of the Non-Invasive Intracranial Pressure Monitoring Device market is characterized by the presence of several established players, emerging startups, and ongoing innovations. Major companies such as Medtronic plc and Codman & Shurtleff, Inc. dominate the market owing to their extensive product portfolios and strong distribution networks. These companies continue to invest heavily in research and development to enhance their existing technologies and introduce new, innovative solutions to meet the growing demand for non-invasive monitoring devices. Additionally, they are actively engaged in strategic partnerships, collaborations, and acquisitions to expand their market presence and leverage synergies in product development and distribution.

Emerging companies like Neuralink and HeadSense Medical Ltd. are leveraging cutting-edge technologies to challenge established players in the non-invasive ICP monitoring space. These companies focus on developing niche solutions that address specific patient needs while offering enhanced user experiences. Their innovative approaches have the potential to disrupt traditional market dynamics and encourage larger companies to adapt and innovate in response. As competition intensifies, collaboration between established players and startups will likely drive further advancements in non-invasive ICP monitoring technologies.

As the market evolves, key companies are also exploring opportunities in emerging markets to capture additional growth. Countries in Asia Pacific and Latin America are becoming increasingly attractive due to their rising healthcare expenditures, improving infrastructure, and growing awareness about the importance of non-invasive monitoring. By strategically positioning themselves in these regions, major companies can capitalize on the expanding demand for advanced medical technologies, thereby solidifying their competitive edge. Ongoing collaboration with regional distributors and government initiatives to improve healthcare accessibility can also help these companies strengthen their foothold in emerging markets.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Raumedic AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 ElMindA Ltd.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Neuroscience Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Philips Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Siemens Healthineers
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Vyaire Medical, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 HeadSense Medical Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Codman & Shurtleff, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Neurotech Solutions, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Natus Medical Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 NeuroVive Pharmaceutical AB
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Honeywell International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Integra LifeSciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Guangzhou Med Equipment Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Non invasive Intracranial Pressure Monitoring Device Sales Market, By Technology
    • 6.1.1 Microstrain Sensor Technology
    • 6.1.2 Optoacoustic Sensor Technology
    • 6.1.3 Transcranial Doppler Technology
    • 6.1.4 MRI Technology
    • 6.1.5 Other
  • 6.2 Non invasive Intracranial Pressure Monitoring Device Sales Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Clinics
    • 6.2.4 Others
  • 6.3 Non invasive Intracranial Pressure Monitoring Device Sales Market, By Product Type
    • 6.3.1 Non-Invasive ICP Sensors
    • 6.3.2 Non-Invasive ICP Monitors
    • 6.3.3 Non-Invasive ICP Transducers
    • 6.3.4 Non-Invasive ICP Systems
    • 6.3.5 Non-Invasive ICP Capsules
  • 6.4 Non invasive Intracranial Pressure Monitoring Device Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Non invasive Intracranial Pressure Monitoring Device Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Non invasive Intracranial Pressure Monitoring Device Sales market is categorized based on

By Product Type

• Non-Invasive ICP Sensors
• Non-Invasive ICP Monitors
• Non-Invasive ICP Transducers
• Non-Invasive ICP Systems
• Non-Invasive ICP Capsules

By Application

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Technology

• Microstrain Sensor Technology
• Optoacoustic Sensor Technology
• Transcranial Doppler Technology
• MRI Technology
• Other

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Codman & Shurtleff, Inc.
• Integra LifeSciences Corporation
• Raumedic AG
• Neurotech Solutions, Inc.
• NeuroVive Pharmaceutical AB
• ElMindA Ltd.
• Natus Medical Incorporated
• Vyaire Medical, Inc.
• Honeywell International Inc.
• Philips Healthcare
• Siemens Healthineers
• Guangzhou Med Equipment Co., Ltd.
• HeadSense Medical Ltd.
• Neuroscience Inc.